{"version":"1.0","provider_name":"EHMA","provider_url":"https:\/\/ehma.org","title":"New report published: Consolidating infant rsv prophylaxis - evidence and policy guidance for European health systems. - EHMA","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"O76MKNCNJS\"><a href=\"https:\/\/ehma.org\/new-report-published-consolidating-infant-rsv-prophylaxis-evidence-and-policy-guidance-for-european-health-systems\/\">New report published: Consolidating infant rsv prophylaxis &#8211; evidence and policy guidance for European health systems.<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/ehma.org\/new-report-published-consolidating-infant-rsv-prophylaxis-evidence-and-policy-guidance-for-european-health-systems\/embed\/#?secret=O76MKNCNJS\" width=\"600\" height=\"338\" title=\"&#8220;New report published: Consolidating infant rsv prophylaxis &#8211; evidence and policy guidance for European health systems.&#8221; &#8212; EHMA\" data-secret=\"O76MKNCNJS\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/ehma.org\/wp\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/ehma.org\/app\/uploads\/2026\/01\/Website-Cards-40.png","thumbnail_width":688,"thumbnail_height":650,"description":"At EHMA, we are proud to release our latest policy report on infant RSV prophylaxis, providing the first cross-country evidence on the operational and workforce impacts of introducing long-acting monoclonal antibodies. Our findings show that early adoption can meaningfully reduce seasonal pressures on hospitals, improve patient flow, and support staff wellbeing, all without increasing personnel requirements. The report highlights that while health systems are largely ready for technical integration, sustained and equitable uptake also depends on effective public engagement. We encourage European health leaders to use these insights to guide policy, planning, and communication strategies, ensuring every child benefits from preventive care."}